• Skip to primary navigation
  • Skip to main content
  • Skip to primary navigation
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Translational Research Institute
  • UAMS Health
  • Jobs
  • Giving
  • About TRI
    • What We Offer
    • Leadership & Governance
    • Staff
    • Cite TRI
    • What is Translational Research?
    • Contact TRI
  • Funding Opportunities
    • Grants
      • Pilot Award Program
      • Consortium of Rural States (CORES) Multi-Institutional Pilot Award Program
      • Team Science Voucher Program
      • Winthrop P. Rockefeller Cancer Institute Rural Research Award Program
    • Scholarships
      • K12 Mentored Research Career Development Scholar Awards Program
      • HSIE (T32) Training Program
      • Implementation Science Scholar Program
      • (STARs) Program – Strategies for Training and Advancing Researchers
      • SMART Program [Master’s in Clinical and Translational Sciences (MS-CTS)]
    • Community
      • Community Based Participatory Research (CBPR) Scholars Program
      • Community Partners Educated as Arkansas Research Leaders (CPEARL) Program
    • Awardee Responsibilities
  • Services & Resources
    • Services
      • Biostatistics, Epidemiology and Research Design (BERD) Consultation
      • Clinical Data Repository (AR-CDR)
      • Comprehensive Informatics Resource Core (CIRC)
      • Mock Study Sections
      • Research Participant Recruitment
      • Research Support: Clinical Trials Innovation Unit (CTIU)
      • Implementation Science Program
      • Research Ethics Consultation
    • Resources
      • ARresearch Registry
      • Center for Health Literacy
      • Data Safety Monitoring
      • Grant Writing & Dissemination
      • UAMS Profiles
      • UAMS Rural Research Network
      • Other Resources
      • COVID-19 Research Guidelines
      • Community Partner Research Training
  • Career Development & Scholarships
    • Scholarship Opportunities
      • K12 Mentored Research Career Development Scholar Awards Program
      • HSIE (T32) Training Program
      • Data Science Scholars Program
      • Implementation Science Scholar Program
      • SMART Program
      • Translational Research Innovations and Partners (TRIP) Program
    • Training & Educational Opportunities
      • innOVATION Seminar Series
      • Path 2 K Program
      • Translational Workforce Development
      • Graduate Certificate in Implementation Science
      • SMART Program [Master’s in Clinical and Translational Sciences (MS-CTS)]
      • Good Clinical Practice Training
    • Didactic Training
  • Community
    • Community Engagement Leadership
    • Community Advisory Board
    • Community Engagement Partners
      • Community Partner Celebration
      • Faith-Academic Initiatives for Transforming Health (FAITH) Network
    • Community Engagement Services
      • Consultations and Technical Assistance
      • Community Review Boards
      • Community Partner Research Training
      • Equipment Library
    • Programs and Funding
      • Community Partners Educated as Arkansas Research Leaders (CPEARL) Program
      • Community Based Participatory Research (CBPR) Scholars Program
      • Community Scientist Academy
    • Toolkits
      • CSA Online Toolkit
      • CPEARL Toolkit
  • Events
    • Research Day
    • Clinical Trials Learning Collaborative
  • Newsroom
  1. University of Arkansas for Medical Sciences
  2. Translational Research Institute
  3. Services and Resources
  4. TRI Resources
  5. Data Safety Monitoring

Data Safety Monitoring

All research studies involving human subjects must have a Data and Safety Monitoring Plan (DSMP). The Translational Research Institute (TRI) can assist investigators with writing DSMPs that are tailored to the complexity and risk of their research studies. Such plans can be included as part of grant applications, study protocols, and IRB submissions.

There are several occasions when a formal, independent Data and Safety Monitoring Board (DSMB) may be warranted. DSMBs regularly review accumulating data for ongoing research studies to assess subject safety, scientific validity, and efficacy. TRI can also assist with the organization and implementation of DSMBs for specific research projects. The Food and Drug Administration (FDA) offers a guidance document that provides recommendations on when a DSMB may be required. Individual funding agencies, including the National Institutes of Health (NIH), may also impose additional DSMB requirements. Please check with your funding agency to determine whether they have their own system for oversight or particular requirements.

Useful Links

  • CTSA DSMB Training Manual
  • NIH Data Safety and Monitoring
  • NIH DSMP Guidance
  • NIH DSM Policies and Guidance
  • NIH Adverse Events

Elements of a Data and Safety Monitoring Plan

  • Risk Assessment. This section of the plan should include adverse event grading (serious vs. non-serious) and attribution (i.e. relationship to investigational product) scales. This section should also assess if the study is minimal risk, greater than minimal risk, or uncertain risk. If greater than minimal risk or uncertain risk, explicit details for managing safety issues that could lead to study interruption and/or termination should be included.
  • Monitoring Plan. This section should address who will monitor the study (e.g., principal investigator, members of the investigative team, independent DSMB) and how often the study will be monitored. If the study is being conducted under an investigational new drug (IND) application or investigational device exemption (IDE), the sponsor’s monitoring plans should also be included.
  • Interim Study Analysis. This section applies to clinical trials in which clinical implications or safety dictate that the trial should be stopped early if significant positive or negative findings emerge. Plans for interim data analysis should be detailed along with stopping rules, if applicable.
  • Reporting Plans. This section should specify how and when adverse events (AEs), serious adverse events (SAEs), and unanticipated adverse device effects (UADEs) will be reported and to whom (e.g., institutional review board, sponsor, TRI, funding agency, etc).
  • Data Accuracy and Protocol Compliance. This section should describe how adherence to the protocol will be assured, how data will be handled and stored, and any security measurements used to protect the data. Confidentiality issues should be addressed as well.
  • Conflict of Interest. This section should describe any possible conflicts of interest among the investigator(s) or study team and how these potential conflicts will be managed so that objectivity and subject safety are safeguarded.

Translational Research Institute LogoTranslational Research InstituteTranslational Research Institute
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement

© 2025 University of Arkansas for Medical Sciences